UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 361

Sortiert nach

From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)

International journal of oncology, 2019-02, Vol.54 (2), p.407-419

Schirrmacher, Volker

2019

Link zum Volltext

Verfügbarkeit prüfen

Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism

Biomedicines, 2020-11, Vol.8 (11), p.526

Schirrmacher, Volker

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients

International journal of molecular sciences, 2017-05, Vol.18 (5), p.1103

Schirrmacher, Volker

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis

Biomedicines, 2020-03, Vol.8 (3), p.61

Schirrmacher, Volker

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus

Biomedicines, 2022-02, Vol.10 (3), p.562

Schirrmacher, Volker

2022

Link zum Volltext

Verfügbarkeit prüfen

Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate

Biomedicines, 2016-07, Vol.4 (3), p.16

Schirrmacher, Volker

2016

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow: The Central Immune System

Immuno, 2023-09, Vol.3 (3), p.289-329

Schirrmacher, Volker

2023

Link zum Volltext

Verfügbarkeit prüfen

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy

International journal of molecular sciences, 2022-11, Vol.23 (21), p.13050

2022

Link zum Volltext

Verfügbarkeit prüfen

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy

Biomedicines, 2019-08, Vol.7 (3), p.66

2019

Link zum Volltext

Verfügbarkeit prüfen

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Methods in molecular biology (Clifton, N.J.), 2009, Vol.542, p.565

2009

Link zum Volltext

Verfügbarkeit prüfen

Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

Biomedicines, 2024-04, Vol.12 (4), p.754

2024

Link zum Volltext

Verfügbarkeit prüfen

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Journal of Virology, 2009-08, Vol.83 (16), p.8108-8121

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

Cancers, 2020-12, Vol.13 (1), p.32

2020

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

Expert opinion on biological therapy, 2015-12, Vol.15 (12), p.1757-1771

Schirrmacher, Volker

2015

Link zum Volltext

Verfügbarkeit prüfen

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Expert review of vaccines, 2014-01, Vol.13 (1), p.117-130

2014

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host

Biology, 2013-07, Vol.2 (3), p.936-975

2013

Link zum Volltext

Verfügbarkeit prüfen

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

Cancers, 2023-02, Vol.15 (4), p.1194

2023

Link zum Volltext

Verfügbarkeit prüfen

Signaling through RIG-I and type I interferon receptor: Immune activation by Newcastle disease virus in man versus immune evasion by Ebola virus (Review)

International journal of molecular medicine, 2015-07, Vol.36 (1), p.3-10

SCHIRRMACHER, VOLKER

2015

Link zum Volltext

Verfügbarkeit prüfen

Cancer-reactive memory T cells from bone marrow: Spontaneous induction and therapeutic potential (Review)

International journal of oncology, 2015-12, Vol.47 (6), p.2005-2016

SCHIRRMACHER, VOLKER

2015

Link zum Volltext

Verfügbarkeit prüfen

The hemagglutinin–neuraminidase gene of Newcastle Disease Virus: A powerful molecular adjuvant for DNA anti-tumor vaccination

Vaccine, 2010-10, Vol.28 (42), p.6891-6900

2010

Link zum Volltext

Verfügbarkeit prüfen

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit

Biomedicines, 2020-07, Vol.8 (8), p.237

2020

Link zum Volltext

Verfügbarkeit prüfen

The Application of Evidence-Based Medicine in Individualized Medicine

Biomedicines, 2023-06, Vol.11 (7), p.1793

2023

Link zum Volltext

Verfügbarkeit prüfen

Antitumor Vaccination of Patients With Glioblastoma Multiforme: A Pilot Study to Assess Feasibility, Safety, and Clinical Benefit

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4272-4281

2004

Link zum Volltext

Verfügbarkeit prüfen

Cell Surface Expression and Secretion of Heparanase Markedly Promote Tumor Angiogenesis and Metastasis

Proceedings of the National Academy of Sciences - PNAS, 2002-07, Vol.99 (15), p.10031-10036

2002

Link zum Volltext

Verfügbarkeit prüfen

Harnessing oncolytic virus-mediated immunity

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 361

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(260)

Publikationsform

Sprache

Englisch
(351)
Japanisch
(14)
Deutsch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(191)
Life Sciences & Biomedicine
(185)
Animals
(157)
Mice
(129)
Oncology
(117)
Humans
(109)
Biological And Medical Sciences
(104)
Medical Sciences
(87)
Tumors
(74)
Mice, Inbred Dba
(62)
Female
(57)
Immunology
(56)
T-Lymphocytes - Immunology
(51)
Newcastle Disease Virus
(48)
Immunotherapy
(39)
Newcastle Disease Virus - Immunology
(34)
Neoplasm Metastasis
(30)
Cell Line
(29)
Tumor Cells, Cultured
(29)
Medicine, Research & Experimental
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)

Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism

Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients

Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis

Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus

Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate

Bone Marrow: The Central Immune System

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution

Activation of Natural Killer Cells by Newcastle Disease Virus Hemagglutinin-Neuraminidase

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

Signaling through RIG-I and type I interferon receptor: Immune activation by Newcastle disease virus in man versus immune evasion by Ebola virus (Review)

Cancer-reactive memory T cells from bone marrow: Spontaneous induction and therapeutic potential (Review)

The hemagglutinin–neuraminidase gene of Newcastle Disease Virus: A powerful molecular adjuvant for DNA anti-tumor vaccination

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit

The Application of Evidence-Based Medicine in Individualized Medicine

Antitumor Vaccination of Patients With Glioblastoma Multiforme: A Pilot Study to Assess Feasibility, Safety, and Clinical Benefit

Cell Surface Expression and Secretion of Heparanase Markedly Promote Tumor Angiogenesis and Metastasis

Harnessing oncolytic virus-mediated immunity

Suchergebnisse filtern